Collagen Solutions PLC (LSE:COS) - Overview

Stock Report

Collagen Solutions PLC COS

Last Price
GBX6.25

Day Change
0.00|0.00%

As of 09/12/2016
11:11:27 GMT | GBX
Minimum 15 Minutes Delay.

Last Close6.25p
Day Range6.40 - 6.42
Mkt Cap11.23Mil
52-Wk Range5.00 - 10.25
Yield %0.00
ISINGB00B94T6Y14
Volume12,000
P/E-10.95
P/S3.42
P/CF-57.87

Share Price

Total Returns 09/12/2016

 Chg (%)  
More ...
Collagen Solutions PLC-7.41 
FTSE 100 TR GBP1.05
 
Financials
201420152016
More ...
Income Statement
Turnover0.020.973.13
Operating Profit-0.48-0.98-0.60
Net Profit-0.48-1.12-0.98
Reported EPS-1.10-1.17-0.57
Balance Sheet
Current Assets1.704.253.39
Non Current Assets7.1313.7114.13
Total Assets8.8217.9717.53
Current Liabilities0.160.420.88
Total Liabilities2.575.113.63
Total Equity6.2612.8513.90
Cash Flow
Operating Cash Flow-0.53-1.040.01
Net Change in Cash1.491.89-0.88
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-1.21-0.86--7.29---
2018-0.78-0.58--10.83---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/07/2016PurchaseMr. David Evans8.15185,00015,078.00
11/07/2016PurchaseMr. David Evans6.00900,00054,000.00
11/07/2016PurchaseMr. David Evans8.001,215,00097,200.00
21/01/2016PurchaseMr. David Evans7.501,000,00075,000.00

Company Profile

Collagen Solutions PLC is engaged in the supply, development and manufacture of medical grade collagen components and biomaterials for use in regenerative medicine, medical devices and in-vitro diagnostics.
 

Sector

Biotechnology

Market Position

1476 of 1863 Companies

Index

FTSE AIM All Share

Outlook

(13/10/2016) "Revenue and other income is expected to be £1.90m, which represents a 30.0% increase compared to revenue of £1.46m for the same period last year"

Next Event 19/12/2016

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-9.4317.1916.09
Div Yld (E)0.001.954.23
PEG (E)0.001.570.59
ROCE-23.0733.8179.03
Op Mrgn-27.76-23.40-13.33
EPS Grwth0.0016.3122.92
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. David Evans
Chief Executive OfficerMr. Jamal Rushdy
Chief Financial Officer & Company SecretMs. Gill Black
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.